Bull of the Day: Amgen (AMGN) – Bull of the Day

Email

Amgen Inc's (AMGN) third quarter EPS of $1.66 per share was 23 cents above the Zacks Consensus Estimate and 19.4% above the year-ago period. Higher revenues, cost discipline and a lower share count contributed to the year-over-year increase in earnings. Revenues increased 9.5% to $4,319 million, well above the Zacks Consensus Estimate of $4,199 million.

Amgen raised its guidance for 2012 again and now expects earnings in the range of $6.50 – $6.60 per share on revenues of $17.2 billion – $17.3 billion. Earlier, the company had guided towards earnings of $6.20 – $6.35 per share on revenues of $16.9 – $17.2 billion.

Based on the company's performance so far this year and the upbeat guidance, which should be easily achievable, we are upgrading Amgen to Outperform. Our $106 price target is based on 15.6x our 2013 earnings estimate.
 
AMGEN INC (AMGN): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Join the conversation. Click here to jump to comments…

Leave a Reply

Your email address will not be published. Required fields are marked *


× 2 = twelve

Some HTML is OK

© 2014 Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201, Email: customerservice@MoneyMorning.com